Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410
Funding
Conflicts of Interest
References
- Rosenzweig, B.; Haramaty, R.; Davidson, T.; Lazarovich, A.; Shvero, A.; Haifler, M.; Gal, J.; Golan, S.; Shpitzer, S.; Hoffman, A.; et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410. [Google Scholar] [CrossRef] [PubMed]
- Veerman, H.; Donswijk, M.; Bekers, E.; Olde Heuvel, J.; Bodar, Y.J.L.; Boellaard, T.N.; van Montfoort, M.L.; van Moorselaar, R.J.A.; Oprea-Lager, D.E.; van Leeuwen, P.J.; et al. The clinical characteristics of patients with primary non-prostate-specific membrane antigen-expressing prostate cancer on preoperative positron emission tomography/computed tomography. BJU Int. 2021, 129, 314–317. [Google Scholar] [CrossRef] [PubMed]
- Uprimny, C.; Kroiss, A.S.; Decristoforo, C.; Fritz, J.; von Guggenberg, E.; Kendler, D.; Scarpa, L.; di Santo, G.; Roig, L.G.; Maffey-Steffan, J.; et al. 68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour. Eur. J. Nucl. Med. Mol. Imaging 2017, 44, 941–949. [Google Scholar] [CrossRef] [PubMed]
- Jiao, J.; Kang, F.; Zhang, J.; Quan, Z.; Wen, W.; Zhao, X.; Ma, S.; Wu, P.; Yang, F.; Guo, W.; et al. Establishment and prospective validation of an SUV max cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by 68 Ga-PSMA PET/CT: A real-world study. Theranostics 2021, 11, 8396–8411. [Google Scholar] [CrossRef] [PubMed]
- Boellaard, R.; Willemsen, A.T.; Arends, B.; Visser, E.P. EARL procedure for assessing PET/CT system specific patient FDG activity preparations for quantitative FDG PET/CT studies. Eur. J. Nucl. Med. Mol. Imaging 2014, 42, 328–354. [Google Scholar] [CrossRef] [PubMed]
- Ceci, F.; Oprea-Lager, D.E.; Emmett, L.; Adam, J.A.; Bomanji, J.; Czernin, J.; Eiber, M.; Haberkorn, U.; Hofman, M.S.; Hope, T.A.; et al. E-PSMA: The EANM standardized reporting guidelines v1.0 for PSMA-PET. Eur. J. Nucl. Med. Mol. Imaging 2021, 48, 1626–1638. [Google Scholar] [CrossRef] [PubMed]
- Bodar, Y.J.L.; Veerman, H.; Meijer, D.; de Bie, K.; van Leeuwen, P.J.; Donswijk, M.L.; van Moorselaar, R.J.; Hendrikse, N.H.; Boellaard, R.; Oprea-Lager, D.E.; et al. Standardised Uptake Values as Determined on PSMA PET/CT is associated with Oncological Outcomes in Prostate Cancer Patients. BJU Int. 2022, 1–8. [Google Scholar] [CrossRef]
- Roberts, M.J.; Morton, A.; Papa, N.; Franklin, A.; Raveenthiran, S.; Yaxley, W.J.; Coughlin, G.; Gianduzzo, T.; Kua, B.; McEwan, L.; et al. Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy. Eur. J. Nucl. Med. Mol. Imaging 2022, 1–6. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Veerman, H.; Vis, A.N.; Donswijk, M.; van der Poel, H.G. Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410. J. Pers. Med. 2022, 12, 800. https://doi.org/10.3390/jpm12050800
Veerman H, Vis AN, Donswijk M, van der Poel HG. Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410. Journal of Personalized Medicine. 2022; 12(5):800. https://doi.org/10.3390/jpm12050800
Chicago/Turabian StyleVeerman, Hans, André N. Vis, Maarten Donswijk, and Henk G. van der Poel. 2022. "Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410" Journal of Personalized Medicine 12, no. 5: 800. https://doi.org/10.3390/jpm12050800